Cite
MLA Citation
Jean-Pierre J Issa et al.. “Safety and tolerability of guadecitabine (SGI-110) in patients with myelodysplastic syndrome and acute myeloid leukaemia: a multicentre, randomised, dose-escalation phase 1 study.” Lancet oncology, vol. 16, no. 9, n.d., pp. 1099–1110. http://access.bl.uk/ark:/81055/vdc_100026480219.0x000003